Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Apple Apple     
Registreren
Of aanmelden met
GoogleGoogle
Apple Apple     

Toonaangevende leiders

HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŰn van bedrijfsleiders 
Portrait de Eric K. Rowinsky
Leeftijd : 65
Vermogen : 4 879 480 USD
Belangrijkste bedrijven : Biogen Inc. - Everest Medicines Limited - Verastem, Inc. - Purple Biotech Ltd. - Fortress Biotech, Inc.
Overzicht 
Founder of Primrose Therapeutics, Inc., Eric K. Rowinsky presently is Chairman at Purple Biotech Ltd., Executive Chairman & President at Inspirna, Inc., Chief Scientific Officer of Clearpath Development Co. and Chief Medical Officer for Hummingbird Bioscience. Dr. Rowinsky is also Consulting Chief Medical Officer at Everest Medicines Ltd. and Consulting Chief Medical Officer at Oncotartis, Inc. and on the board of 8 other companies.

Dr. Rowinsky previously was Chairman for Navidea Biopharmaceuticals, Inc., Chief Executive Officer for Primrose Therapeutics, Inc., Chief Medical Officer of Champions Oncology, Inc., Chief Medical Officer & Executive Vice President at ImClone LLC, CMO, EVP & Head-Research & Development at Stemline Therapeutics, Inc., Director-Drug Development Institute at Cancer Therapy & Research Center Endowment, Director at Biogen Idec New Ventures, Inc., Advisor at Maxwell Asset Management LLC (US), Chairman-Early Drug Development at IDD, Inc., Principal at National Cancer Institute, Clinical Professor-Medicine at Texas University of Health Center at San Antonio, Associate Professor-Oncology at The Johns Hopkins University School of Medicine, Adjunct Professor at New York University School of Medicine and Professor at the University of Texas Health Science Center At San Antonio.

He received an undergraduate degree from New York University and a doctorate from Vanderbilt University School of Medicine.


Posities en verantwoordelijkheden van Eric K. Rowinsky 
NaamTitel Van
Biogen Inc.
(Farmaceutische producten)
Independent Director 2011
Verastem, Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2017
Purple Biotech Ltd.
(Biotechnologie & Medisch Onderzoek)
Chairman 2019
Fortress Biotech, Inc.
(Farmaceutische producten)
Vice Chairman 2010
Everest Medicines Limited
(Farmaceutische producten)
Consulting Chief Medical Officer 2017
Clearpath Development Co. Chief Scientific Officer 2016
Hummingbird Bioscience Chief Medical Officer -
Biogen Idec, Inc. (North Carolina) Director -
Biogen GmbH Member-Supervisory Board 2010
Cage Pharma, Inc. Director -
Inspirna, Inc. Executive Chairman & President -
BioXcel Corp. Director 2017
Tusk Therapeutics Ltd. Director -
Oncotartis, Inc. Consulting Chief Medical Officer 2018


Belangnemingen van Eric K. Rowinsky 
NaamAandelen%Totale waarde
Biogen Inc. (BIIB)
(Farmaceutische producten)
20 1740,014%4 792 132 USD
Fortress Biotech, Inc. (FBIO)
(Farmaceutische producten)
48 7980,55%87 348 USD
Verastem, Inc. (VSTM)
(Biotechnologie & Medisch Onderzoek)
00,0000%0 USD


Eric K. RowinskyPersoonlijk netwerk 
Meest gelezen nieuws 
17/11Witte Huis veroordeelt Musk voor het verspreiden van "afschuwelijke" antisemitische leugens
MR
22/11LVMH erfgenaam Antoine Arnault stapt uit managementrol Berluti
MR
22/11Factbox-LVMH functies bekleed door Bernard Arnault's kinderen
MR
17/11Fed's Collins: Niet klaar om te zeggen dat de renteverhogingscyclus voorbij is
MR
26/11Duitse Kuehne onderzoekt bod op wolkenkrabber Signa Hamburg - rapport
MR
28/11Berkshire Hathaway vicevoorzitter Charlie Munger overlijdt op 99-jarige leeftijd
MR
28/11Charlie Munger, het 'Orakel van Pasadena' die Buffetts rechterhand was
MR
28/11Elon Musk belooft symbool van gijzelaar in Gaza te dragen
MR
19/11Tattarang van de Australische Forrests neemt 'iconisch' hoedenbedrijf Akubra over
MR
21/11Ryanair's O'Leary doet onderzoek naar Italiaanse prijzen af als "grap
MR
Meer nieuws


© 2023 People and Ownership :   
Eric K. Rowinsky Verbindingen 


-40% Black Friday : Onze betaalabonnementen leiden je naar de beste beleggingen van morgen.Profiteer van het aanbod
Profiteer van het aanbod